All news articles for April 2014

Endo acquires migraine treatment, needle-free delivery system for $85M

Endo acquires migraine treatment, needle-free delivery system for $85M

By Zachary Brennan

Endo Pharmaceuticals, which previously lost a bid to acquire a migraine treatment, has now acquired worldwide rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use, which is a needle-free delivery system for Zogenix’s migraine treatment...